Skip to main content
. 2020 Jan 27;12(2):333. doi: 10.3390/nu12020333

Table 2.

Differences between NKF and MCKD before and after treatment.

NKF (e GFR ≥ 90) MCKD (eGFR 60–89)
Variable Baseline End of Diet p Baseline End of Diet p p *
N 54 NA 38 NA
Female gender n (%) 43 (80) NA 22 (68) NA 0.22
HTN treatment n (%) 20 (43.5) NA 19 (44.2) NA
Diet length (weeks) 15.33 ± 7.98 NA 15.33 ± 7.98 NA 0.645
Age (years) 47.96 ± 12.97 NA 55.97 ± 9.30 NA <0.0001
Weight (Kg) 94.21 ± 18.60 77.94 ± 15.67 <0.0001 89.92 ± 17.84 75.28 ± 13.95 <0.0001 0.510
BMI (kg/m2) 34.46 ± 5.69 28.67 ± 5.04 <0.0001 33.01 ± 6.01 27.56 ± 4.68 <0.0001 0.334
Fat Mass (Kg) 37.51 ± 9.57 25.93 ± 9.45 <0.0001 33.05 ± 9.96 22.31 ± 7.99 <0.0001 0.742
Fat Free Mass (Kg) 56.69 ± 14.10 52.01 ± 11.10 <0.0001 56.88 ± 12.55 52.97 ± 10.72 <0.0001 0.521
Skeletal Muscle Mass (Kg) 37.08 ± 10.05 33.58 ± 8.14 <0.0001 37.54 ± 9.00 34.40 ± 8.13 <0.0001 0.542
TBW (Lt) 42.04 ± 10.00 38.60 ± 7.86 <0.0001 42.98 ± 9.76 40.03 ± 8.47 <0.0001 0.494
ECW (Lt) 19.53 ± 4.49 18.42 ± 4.04 <0.0001 19.74 ± 4.50 18.78 ± 3.90 <0.0001 0.238
ICW (Lt) 22.51 ± 5.91 20.37 ± 4.78 <0.0001 23.20 ± 5.67 21.23 ± 5.19 <0.0001 0.561
SBP (mmHg) 136.6 ± 14.5 130.9 ± 10.8 <0.0001 137.6 ± 12.2 132.2 ± 9.2 <0.0001 0.998
DBP (mmHg) 82.6 ± 7.2 77.3 ± 5.2 <0.0001 81.4 ± 6.7 77.4 ± 4.6 <0.0001 0.841
Creatinine (mg/dL) 0.70 ± 0.11 0.71 ± 0.12 0.43 0.93 ± 0.16 0.88 ± 0.17 0.002 0.414
eGFR (ml/min/1.73m2) 107.22 ± 11.20 105.28 ± 14.32 0.263 76.32 ± 10.44 82.21 ± 15.14 0.002 0.901
BUN (g/L) 0.34 ± 0.08 0.38 ± 0.07 <0.0001 0.39 ± 0.11 0.41 ± 0.11 0.052 0.822
Glucose (mg/dL) 96.7 ± 14.5 91.73 ± 15.23 0.002 91.59 ± 11.0 86.60 ± 10.02 0.005 0.053
HbA1c (%) 5.68 ± 0.96 5.30 ± 0.38 <0.0001 5.60 ± 0.46 5.39 ± 0.40 0.007 0.470
AST (mg/dL) 28.33 ± 19.49 22.08 ± 6.71 0.218 20.44 ± 6.17 19.36 ± 5.26 0.732 0.724
ALT (mg/dL) 38.07 ± 31.45 26.23 ± 15.35 0.15 22.11 ± 9.85 20.42 ± 8.36 0.759 0.766
Total cholesterol (mg/dL) 206.65 ± 48.24 182.61 ± 35.54 <0.0001 207.27 ± 43.62 187.13 ± 49.28 0.148 0.279
LDL (mg/dL) 122.74 ± 44.53 121.71 ± 30.31 0.233 117.04 ± 42.32 113.04 ± 46.14 0.958 0.309
HDL (mg/dL) 53.59 ± 9.59 51.21 ± 8.61 0.491 58.67 ± 25.13 52.25 ± 14.27 0.199 0.550
Triglycerides (mg/dL) 172.37 ± 101.64 99.33 ± 30.48 <0.0001 136.27 ± 73.48 106.94 ± 42.28 0.061 0.249
Total Protein (g/dL) 7.11 ± 0.41 7.11 ± 0.40 0.48 7.02 ± 0.34 7.00 ± 0.38 0.352 0.185
Albumin (g/dL) 4.08 ± 0.26 4.17 ± 0.27 <0.0001 4.21 ± 0.21 4.20 ± 0.30 0.968 0.226
Uric Acid (mg/dL) 5.06 ± 0.98 4.75 ± 1.21 <0.0002 5.49 ± 1.10 4.96 ± 0.94 0.008 0.561
Calcium (mg/dL) 9.41 ± 0.46 9.56 ± 0.44 <0.0003 9.42 ± 0.39 9.59 ± 0.44 0.002 0.401
Phosphorus (mg/dL) 3.46 ± 0.54 3.67 ± 0.49 <0.0004 3.62 ± 0.45 3.75 ± 0.39 0.168 0.864
Sodium (mmol/L) 140.60 ± 2.30 141.16 ± 2.02 0.113 141.89 ± 2.49 142.00 ± 2.06 0.865 0.883
Potassium (mmol/L) 4.48 ± 0.43 4.51 ± 0.42 0.345 4.59 ± 0.35 4.62 ± 0.36 0.505 0.920
PTHi (ng/L) 39.04 ± 11.89 36.66 ± 14.54 0.627 32.33 ± 8.16 29.67 ± 7.42 0.33 0.528
Ferritin (ug/L) 121.56 ± 146.19 90.44 ± 67.44 0.238 95.21 ± 74.22 116.14 ± 67.74 0.036 0.449
Urinary protein (mg/dL) 13.54 ± 10.74 11.34 ± 7.30 0.157 10.74 ± 7.16 10.56 ± 6.98 0.882 0.577

Data shown as means ± standard deviation (SD) of the mean. The p value is from a dependent sample t-test for the within group analysis. The p * value shown is from a general linear mixed model analysis of end of diet variables of the NF and MCKD groups for the between groups analysis. The variables of group, baseline values, age and gender were included in the model as fixed effects. For BP, HTN treatment was taken into account. NA, not applicable; NKF, Normal Kidney Function; MCKD, Mild Chronic Kidney Disease; HTN, hypertension; BMI, Body Mass Index; TBW, Total Body Water; ECW Extra Cellular Water; ICW Intra Cellular Water; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; eGFR, estimated Glomerular Filtration Rate; BUN, Blood Urea Nitrogen; LDL, Low Density Lipoprotein; HDL, High Density Lipoprotein. Significant p values are highlighted in bold.